Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | CA5A | P35218 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ACP3 | P15309 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MMP14 | P50281 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22999982 | 1.00 | CA2 (0.60) | CA2CA4CA5ALMNATSHR | |
| SCHEMBL22064852 | 0.92 | CA2 (0.52) | CA2CA4CA5ALMNATSHR | |
| SCHEMBL2171752 | 0.90 | CA2 (0.71) | CA2CA4CA5ALMNATSHR | |
| SCHEMBL753791 | 0.89 | CA2 (0.71) | CA2CA4CA5AACP3PTPN5 | |
| SCHEMBL28886060 | 0.89 | ESR1 (0.55) | CA2CA4CA5ALMNAMEN1 | |
| Hydrochloric Acid SCHEMBL28980267 | 0.87 | CA2 (0.68) | CA2CA4CA5AACP3PTPN5 | |
| SCHEMBL5582366 | 0.87 | CA2 (0.48) | CA2CA4CA5ALMNATSHR | |
| SCHEMBL11809603 | 0.87 | LMNA (0.62) | CA2CA4CA5ALMNATSHR | |
| SCHEMBL22999964 | 0.85 | ESR1 (0.46) | CA2CA4CA5ACYP1A2CYP2C19 | |
| SCHEMBL22999958 | 0.85 | CA2 (0.52) | CA2CA4CA5AACP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317785-A1 | CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF | UTI LIMITED PARTNERSHIP (CA) | 2024-09-26 | — | — | US | claimed |
| WO-2022160045-A1 | CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF | UTI LIMITED PARTNERSHIP (CA) | 2022-08-04 | — | — | WO | claimed |
| WO-2018204595-A1 | METAL ORGANIC FRAMEWORKS, THEIR SYNTHESIS AND USE | ExxonMobil Research an Engineering Company (US) | 2018-11-08 | — | — | WO | claimed |
| US-20180318815-A1 | METAL ORGANIC FRAMEWORKS, THEIR SYNTHESIS AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2018-11-08 | — | — | US | claimed |
| US-20080131709-A1 | COMPOSITE STRUCTURE WITH ORGANOPHOSPHONATE ADHERENT LAYER AND METHOD OF PREPARING | ACULON INC. (US) | 2008-06-05 | — | — | US | claimed |
| WO-2008039959-A2 | COMPOSITE STRUCTURE WITH ORGANOPHOSPHONATE ADHERENT LAYER AND METHOD OF PREPARING | ACULON INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-12615910-B2 | Organic light emitting diode and organic light emitting device | LG DISPLAY CO., LTD. (KR) | 2026-04-28 | — | — | US | disclosed |
| EP-4404718-B1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO LTD (KR) | 2025-12-24 | — | — | EP | disclosed |
| EP-4018465-B1 | SUPERCAPACITORS COMPRISING PHOSPHONATE AND ARSONATE METAL ORGANIC FRAMEWORKS (MOFS) AS ACTIVE ELECTRODE MATERIALS | UNIV BERLIN TECH (DE) | 2025-12-17 | — | — | EP | disclosed |
| US-20250296942-A1 | Phosphonate-Based Coordination Complexes and Methods of Preparation and Use Thereof | LOPEZ MEJIAS VILMALI (US) | 2025-09-25 | — | — | US | disclosed |
| WO-2025056534-A1 | OPTOELECTRONIC COMPONENT COMPRISING AN INORGANIC PEROVSKITE SUBCELL AND A PROCESS FOR MANUFACTURING SUCH INORGANIC PEROVSKITE SUBCELL OF AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2025-03-20 | — | — | WO | disclosed |
| US-20250083430-A1 | BIODEGRADABLE LAMINATE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-03-13 | — | — | US | disclosed |
| EP-4521892-A1 | OPTOELECTRONIC COMPONENT COMPRISING AN INORGANIC PEROVSKITE SUBCELL AND A PROCESS FOR MANUFACTURING SUCH INORGANIC PEROVSKITE SUBCELL OF AN OPTOELECTRONIC COMPONENT | Heliatek GmbH (DE) | 2025-03-12 | — | — | EP | disclosed |
| EP-0492694-B1 | Tetravalent metal diphosphonate-phosphite composition in microporous solid cristalline form, with a narrow micropore distribution | ENIRICERCHE SPA (IT) | 1996-10-16 | — | — | EP | disclosed |
| EP-0469682-B1 | Mesoporous crystalline compound of a tetravalent metal | ENIRICERCHE SPA (IT) | 1994-12-14 | — | — | EP | disclosed |
| US-5290746-A | Tetravalent metal diphosphonate-phosphite composition in microporous solid crystalline form, with a narrow micropore distribution | ENIRICERCHE S.P.A. (IT) | 1994-03-01 | — | — | US | disclosed |
| US-5246901-A | POLYSULFONIC ACIDS | CATALYTICA, INC. (US) | 1993-09-21 | — | — | US | disclosed |
| US-5166380-A | MESOPOROUS CRYSTALLINE SOLID COMPOUND OF A DIPHOSPHONATE/PHOSPHITE OF A TETRAVALENT METAL, WITH A NARROW DISTRIBUTION OF MESOPORES | ENIRICERCHE S.P.A. (IT) | 1992-11-24 | — | — | US | disclosed |
| EP-0492694-A1 | Tetravalent metal diphosphonate-phosphite composition in microporous solid cristalline form, with a narrow micropore distribution | ENIRICERCHE S.p.A. (IT) | 1992-07-01 | — | — | EP | disclosed |
| EP-0469682-A1 | Mesoporous crystalline compound of a tetravalent metal | ENIRICERCHE S.p.A. (IT) | 1992-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240317785-A1 | CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF | PPIP5K2, IPMK, POF1B | CA2 149/4885CA4 289/4885CA5A 701/4885 |
| US-20250296942-A1 | Phosphonate-Based Coordination Complexes and Methods of Preparation and Use Thereof | PHOSPHO1, PPIP5K2, INPP5B | CA2 111/4885CA4 293/4885CA5A 1971/4885 |
| US-12615910-B2 | Organic light emitting diode and organic light emitting device | OR10J3, OCIAD2, CTNND1 | CA2 4427/4885CA4 4049/4885CA5A 4811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.